Short Interest in Humacyte, Inc. (NASDAQ:HUMAW) Expands By 6.5%

Humacyte, Inc. (NASDAQ:HUMAWGet Rating) was the target of a large growth in short interest in February. As of February 28th, there was short interest totalling 4,900 shares, a growth of 6.5% from the February 13th total of 4,600 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is presently 0.4 days.

Humacyte Stock Performance

Humacyte stock opened at $0.67 on Friday. The firm’s fifty day moving average is $0.60. Humacyte has a fifty-two week low of $0.38 and a fifty-two week high of $2.38.

Institutional Trading of Humacyte

A hedge fund recently bought a new stake in Humacyte stock. Josh Arnold Investment Consultant LLC acquired a new stake in shares of Humacyte, Inc. (NASDAQ:HUMAWGet Rating) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 237,693 shares of the company’s stock, valued at approximately $93,000. Humacyte makes up approximately 0.1% of Josh Arnold Investment Consultant LLC’s holdings, making the stock its 17th biggest position.

Further Reading

Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with's FREE daily email newsletter.